Hiroyuki Ishibashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroyuki Ishibashi has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Masanori Takahashi
Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba, 260-8670, Japan
12 shared publications- Hitoshi Maruyama
Department of Gastroenterology, Juntendo University, Tokyo, Japan
10 shared publications Osamu Yokosuka
Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba, 260-8670, Japan
9 shared publicationsFumio Imazeki
Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba, 260-8670, Japan
4 shared publicationsTaro Shimada
Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba, 260-8670, Japan
4 shared publicationsHidehiro Kamesaki
Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chuou-ku, Japan
3 shared publications
Latest Publications
- 23 April 2022
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 37 (6) , 445-451
Site-specific mechanical properties of the human great saphenous vein: Cadaveric comparisons among the thigh, knee, and lower leg harvest sites
Background: This study aimed to determine site-specific mechanical properties of the great saphenous vein (GSV) harvested from various sites in the same cadaver. Methods: GSV samples were harvested from three sites: the thigh, knee, and lower leg. The thickness and diameter of the samples were measured, and the tensile test was performed to measure stiffness and Young’s modulus. Results: The stiffness of the GSV harvested from knees in the longitudinal direction was lower than those from other sites, whereas the stiffness of the GSV harvested from the lower leg in the circumferential direction was lower than that from the thigh. Conclusions: The GSV has site-specific mechanical properties. Thus, in addition to morphological evaluations such as echo and computed tomography in preoperative graft surgical evaluations, knowledge of the mechanical properties at each site can improve the patency rate and prevent aneurysmal expansion.
- 23 April 2022
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 37 (6) , 445-451
Site-specific mechanical properties of the human great saphenous vein: Cadaveric comparisons among the thigh, knee, and lower leg harvest sites
Background: This study aimed to determine site-specific mechanical properties of the great saphenous vein (GSV) harvested from various sites in the same cadaver. Methods: GSV samples were harvested from three sites: the thigh, knee, and lower leg. The thickness and diameter of the samples were measured, and the tensile test was performed to measure stiffness and Young’s modulus. Results: The stiffness of the GSV harvested from knees in the longitudinal direction was lower than those from other sites, whereas the stiffness of the GSV harvested from the lower leg in the circumferential direction was lower than that from the thigh. Conclusions: The GSV has site-specific mechanical properties. Thus, in addition to morphological evaluations such as echo and computed tomography in preoperative graft surgical evaluations, knowledge of the mechanical properties at each site can improve the patency rate and prevent aneurysmal expansion.
- Open Access
- 25 June 2021
- Published by The Editorial Committee of Annals of Vascular Diseases in Annals of Vascular Diseases
- Vol. 14 (2) , 198-201
A Case of Effective Balloon Fenestration for Localized Aortic Dissection Complicated with Acute Renal and Bilateral Limb Ischemia in a Thoracoabdominal Aortic Aneurysm
An 85-year-old man visited our hospital with bilateral leg weakness. Blood tests revealed an abrupt deterioration of renal function. Computed tomography revealed a 53-mm aortic aneurysm at the level of the diaphragm with an aortic dissection after branching of the superior mesenteric artery. An emergency left axillary–left femoral artery bypass surgery was performed to secure blood flow to the kidneys and lower limbs. Five days later, a transcatheter balloon fenestration for the stenosis was performed, and the blood pressure of the infrarenal aorta was improved. Both the dorsal pedis and posterior tibial arteries became palpable, and renal function was improved.
- 25 June 2021
- Published by The Editorial Committee of Annals of Vascular Diseases in Annals of Vascular Diseases
- Vol. 14 (2) , 198-201
Open AccessA Case of Effective Balloon Fenestration for Localized Aortic Dissection Complicated with Acute Renal and Bilateral Limb Ischemia in a Thoracoabdominal Aortic Aneurysm
An 85-year-old man visited our hospital with bilateral leg weakness. Blood tests revealed an abrupt deterioration of renal function. Computed tomography revealed a 53-mm aortic aneurysm at the level of the diaphragm with an aortic dissection after branching of the superior mesenteric artery. An emergency left axillary–left femoral artery bypass surgery was performed to secure blood flow to the kidneys and lower limbs. Five days later, a transcatheter balloon fenestration for the stenosis was performed, and the blood pressure of the infrarenal aorta was improved. Both the dorsal pedis and posterior tibial arteries became palpable, and renal function was improved.
- 27 May 2015
- Published by IOP Publishing in Applied Physics Express
- Vol. 8 (6) , 062602
High-temperature scintillation properties of orthorhombic Gd2Si2O7aiming at well logging
- 27 May 2015
- Published by IOP Publishing in Applied Physics Express
- Vol. 8 (6) , 062602
High-temperature scintillation properties of orthorhombic Gd2Si2O7aiming at well logging
- 1 January 2014
- Vol. 111 (1) , 105-14
[A case of gastric carcinosarcoma treated with surgical resection and irinotecan and mitomycin C combination therapy].
A 59-year-old man was admitted following episodes of melena. Upper gastrointestinal endoscopy revealed a type 2 carcinoid-like tumor in the cardium of the stomach. Histopathological analysis of a biopsy specimen revealed adenocarcinoma. Although hepatic metastases were detected, total gastrectomy was initially performed for hemorrhage control. The final histopathological diagnosis of the resected primary tumor was gastric carcinosarcoma with an osteosarcoma component. After ineffective first-line combination therapy with S-1 (tegafur, gimeracil, and oteracil) and cisplatin, irinotecan and mitomycin C chemotherapy was introduced. Although the hepatic metastases showed shrinkage after three courses of the chemotherapy, the patient succumbed seven months after surgery. This case report suggests that systemic chemotherapy using irinotecan and mitomycin C may be effective in the treatment of gastric carcinosarcoma with an osteosarcoma component and distant metastases.
- 1 January 2014
- Vol. 111 (1) , 105-14
[A case of gastric carcinosarcoma treated with surgical resection and irinotecan and mitomycin C combination therapy].
A 59-year-old man was admitted following episodes of melena. Upper gastrointestinal endoscopy revealed a type 2 carcinoid-like tumor in the cardium of the stomach. Histopathological analysis of a biopsy specimen revealed adenocarcinoma. Although hepatic metastases were detected, total gastrectomy was initially performed for hemorrhage control. The final histopathological diagnosis of the resected primary tumor was gastric carcinosarcoma with an osteosarcoma component. After ineffective first-line combination therapy with S-1 (tegafur, gimeracil, and oteracil) and cisplatin, irinotecan and mitomycin C chemotherapy was introduced. Although the hepatic metastases showed shrinkage after three courses of the chemotherapy, the patient succumbed seven months after surgery. This case report suggests that systemic chemotherapy using irinotecan and mitomycin C may be effective in the treatment of gastric carcinosarcoma with an osteosarcoma component and distant metastases.
- Open Access
- 1 January 2014
- Published by Ubiquity Press, Ltd. in Data Science Journal
- Vol. 13, PDA51-PDA56
Operation of a Data Acquisition, Transfer, and Storage System for the Global Space-Weather Observation Network
A system to optimize the management of global space-weather observation networks has been developed by the National Institute of Information and Communications Technology (NICT). Named the WONM (Wide-area Observation Network Monitoring) system, it enables data acquisition, transfer, and storage through connection to the NICT Science Cloud, and has been supplied to observatories for supporting space-weather forecast and research. This system provides us with easier management of data collection than our previously employed systems by means of autonomous system recovery, periodical state monitoring, and dynamic warning procedures. Operation of the WONM system is introduced in this report
- 1 January 2014
- Published by Ubiquity Press, Ltd. in Data Science Journal
- Vol. 13, PDA51-PDA56
Open AccessOperation of a Data Acquisition, Transfer, and Storage System for the Global Space-Weather Observation Network
A system to optimize the management of global space-weather observation networks has been developed by the National Institute of Information and Communications Technology (NICT). Named the WONM (Wide-area Observation Network Monitoring) system, it enables data acquisition, transfer, and storage through connection to the NICT Science Cloud, and has been supplied to observatories for supporting space-weather forecast and research. This system provides us with easier management of data collection than our previously employed systems by means of autonomous system recovery, periodical state monitoring, and dynamic warning procedures. Operation of the WONM system is introduced in this report
- 1 December 2013
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 46 (S 01) , E60
Colonoscopy-assisted percutaneous endoscopic gastrostomy to avoid a gastrocolocutaneous fistula of the transverse colon
An 80-year-old woman with a nasogastric tube in situ for cerebral infarction sequelae was referred for percutaneous endoscopic gastrostomy (PEG). The abdominal computed tomography scan on admission showed that the transverse colon was interposed between the anterior abdominal wall and the stomach ([Fig. 1]). The usual PEG placement posed a high risk of piercing the transverse colon. A fluoroscopy-assisted colonoscopy was performed, which showed that the transverse colon was present in the upper abdomen ([Fig. 2 a]). While maintaining the tip of the colonoscope at the hepatic flexure, the transverse colon was moved toward the pelvis under fluoroscopic guidance by using a twisting maneuver of the scope shaft. While the colonoscope was in situ, the esophagogastroduodenoscope was inserted ([Fig. 2 b]). The stomach was expanded as usual to perform the PEG. PEG feeding was initiated as usual without problems. When the PEG button was replaced with a new one 6 months later, no specific abnormalities were observed. Fig. 2 Fluoroscopy-assisted colonoscopy to aid percutaneous endoscopic gastrostomy. a A fluoroscopy-assisted colonoscopy showed that the transverse colon was present in the upper abdomen. Water-soluble contrast medium introduced from the distal end of the scope was seen. b The transverse colon was moved toward the pelvis under fluoroscopic guidance by using a twisting maneuver of the scope shaft. While the colonoscope was in situ, the upper gastrointestinal endoscope was inserted. A gastrocolocutaneous fistula is a rare complication of PEG [1] [2]. It results from the interposition of the colon between the anterior abdominal and gastric walls, so the PEG tube inadvertently passes through the colon into the stomach, resulting in the development of an iatrogenic fistula. The risk of this complication increases in cases of megacolon, subphrenic transposition of the colon, a history of abdominal surgery, or overinflation of the stomach [1] [2]. Colonoscopy-assisted PEG insertion is slightly different from conventional endoscopic methods in terms of its approach. To the best of our knowledge, only one study used both a colonoscope and an esophagogastroduodenoscope for PEG placement [3]. In that report, Tominaga et al. used fluoroscopy to detect sigmoid interposition between the abdominal wall and the stomach; subsequent evacuation of gas from the sigmoid using colonoscopy resulted in successful PEG placement. In the present case, colonoscopy was used to move the transverse colon toward the pelvis under fluoroscopic guidance. Serious complications can be prevented using this method. Endoscopy_UCTN_Code_TTT_1AO_2AK
- 1 December 2013
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 46 (S 01) , E60
Colonoscopy-assisted percutaneous endoscopic gastrostomy to avoid a gastrocolocutaneous fistula of the transverse colon
An 80-year-old woman with a nasogastric tube in situ for cerebral infarction sequelae was referred for percutaneous endoscopic gastrostomy (PEG). The abdominal computed tomography scan on admission showed that the transverse colon was interposed between the anterior abdominal wall and the stomach ([Fig. 1]). The usual PEG placement posed a high risk of piercing the transverse colon. A fluoroscopy-assisted colonoscopy was performed, which showed that the transverse colon was present in the upper abdomen ([Fig. 2 a]). While maintaining the tip of the colonoscope at the hepatic flexure, the transverse colon was moved toward the pelvis under fluoroscopic guidance by using a twisting maneuver of the scope shaft. While the colonoscope was in situ, the esophagogastroduodenoscope was inserted ([Fig. 2 b]). The stomach was expanded as usual to perform the PEG. PEG feeding was initiated as usual without problems. When the PEG button was replaced with a new one 6 months later, no specific abnormalities were observed. Fig. 2 Fluoroscopy-assisted colonoscopy to aid percutaneous endoscopic gastrostomy. a A fluoroscopy-assisted colonoscopy showed that the transverse colon was present in the upper abdomen. Water-soluble contrast medium introduced from the distal end of the scope was seen. b The transverse colon was moved toward the pelvis under fluoroscopic guidance by using a twisting maneuver of the scope shaft. While the colonoscope was in situ, the upper gastrointestinal endoscope was inserted. A gastrocolocutaneous fistula is a rare complication of PEG [1] [2]. It results from the interposition of the colon between the anterior abdominal and gastric walls, so the PEG tube inadvertently passes through the colon into the stomach, resulting in the development of an iatrogenic fistula. The risk of this complication increases in cases of megacolon, subphrenic transposition of the colon, a history of abdominal surgery, or overinflation of the stomach [1] [2]. Colonoscopy-assisted PEG insertion is slightly different from conventional endoscopic methods in terms of its approach. To the best of our knowledge, only one study used both a colonoscope and an esophagogastroduodenoscope for PEG placement [3]. In that report, Tominaga et al. used fluoroscopy to detect sigmoid interposition between the abdominal wall and the stomach; subsequent evacuation of gas from the sigmoid using colonoscopy resulted in successful PEG placement. In the present case, colonoscopy was used to move the transverse colon toward the pelvis under fluoroscopic guidance. Serious complications can be prevented using this method. Endoscopy_UCTN_Code_TTT_1AO_2AK
- 1 May 2012
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 85 (1013) , 587-595
Non-invasive portography: a microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis
The aim of this prospective study was to elucidate the efficacy of contrast-enhanced three-dimensional (3D) ultrasound with Sonazoid(®) (GF Healthcare, Oslo, Norway) as a non-invasive tool to discriminate idiopathic portal hypertension (IPH) from cirrhosis by demonstration of portal vein structure. There were 16 patients: 11 with biopsy-proven cirrhosis and 5 with biopsy-proven IPH. Intrahepatic right portal vein images were taken by 3D ultrasound from 1 min after the injection of Sonazoid (0.0075 ml kg(-1)). Portal vein appearances were compared between 3D ultrasound and percutaneous transhepatic portography (PTP) by four independent reviewers. Sensitivity, specificity and area under the receiver operating characteristic curve (Az) of the images were used for the diagnosis of cirrhosis/IPH, and interimaging, inter-reviewer and interoperator agreement were examined. Sensitivity, specificity and Az of PTP for the diagnosis of cirrhosis/IPH were 63.6%/100%, 100% and 0.9 (0.71-1.0) by Reviewer I and 90.9%/100%, 100% and 1.0 by Reviewer III, respectively. Similarly, sensitivity, specificity and Az of 3D ultrasound for diagnosis of cirrhosis/IPH were 54.5%/80%, 100% and 0.96 (0.84-1.0) by Reviewer II and 72.7%/80%, 100% and 0.97 (0.9-1.0) by Reviewer IV, respectively. Diagnostic agreement between PTP and 3D ultrasound was good between Reviewers I and II (κ=0.793) and good between Reviewers III and IV (κ=0.732). Inter-reviewer agreement was good between Reviewers I and III for PTP diagnosis (κ=0.735), and good between Reviewers II and IV for 3D ultrasound diagnosis (κ=0.792). Interoperator agreement of diagnostic results was good (κ=0.740). Non-invasive visualisation of intrahepatic portal vein structure by contrast-enhanced 3D ultrasound with Sonazoid may have the potential to discriminate IPH from cirrhosis.
- 1 May 2012
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 85 (1013) , 587-595
Non-invasive portography: a microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis
The aim of this prospective study was to elucidate the efficacy of contrast-enhanced three-dimensional (3D) ultrasound with Sonazoid(®) (GF Healthcare, Oslo, Norway) as a non-invasive tool to discriminate idiopathic portal hypertension (IPH) from cirrhosis by demonstration of portal vein structure. There were 16 patients: 11 with biopsy-proven cirrhosis and 5 with biopsy-proven IPH. Intrahepatic right portal vein images were taken by 3D ultrasound from 1 min after the injection of Sonazoid (0.0075 ml kg(-1)). Portal vein appearances were compared between 3D ultrasound and percutaneous transhepatic portography (PTP) by four independent reviewers. Sensitivity, specificity and area under the receiver operating characteristic curve (Az) of the images were used for the diagnosis of cirrhosis/IPH, and interimaging, inter-reviewer and interoperator agreement were examined. Sensitivity, specificity and Az of PTP for the diagnosis of cirrhosis/IPH were 63.6%/100%, 100% and 0.9 (0.71-1.0) by Reviewer I and 90.9%/100%, 100% and 1.0 by Reviewer III, respectively. Similarly, sensitivity, specificity and Az of 3D ultrasound for diagnosis of cirrhosis/IPH were 54.5%/80%, 100% and 0.96 (0.84-1.0) by Reviewer II and 72.7%/80%, 100% and 0.97 (0.9-1.0) by Reviewer IV, respectively. Diagnostic agreement between PTP and 3D ultrasound was good between Reviewers I and II (κ=0.793) and good between Reviewers III and IV (κ=0.732). Inter-reviewer agreement was good between Reviewers I and III for PTP diagnosis (κ=0.735), and good between Reviewers II and IV for 3D ultrasound diagnosis (κ=0.792). Interoperator agreement of diagnostic results was good (κ=0.740). Non-invasive visualisation of intrahepatic portal vein structure by contrast-enhanced 3D ultrasound with Sonazoid may have the potential to discriminate IPH from cirrhosis.
- 27 April 2012
- Published by Springer Nature in Hepatology International
- Vol. 7 (2) , 749-757
Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models
Purpose To elucidate the efficiency of contrast-enhanced ultrasonography alone and in combination with other noninvasive models for grading hepatic fibrosis. Methods This prospective study included 74 patients with four grades (F1–F4) of chronic liver disease (17, 20, 18, and 19 patients, respectively). Diagnostic performances of the contrast parameter (time to the maximum intensity ratio between the right portal vein and liver parenchyma from the onset of contrast enhancement in the right portal vein) assessed by ultrasonography, liver stiffness measurement (LSM), FIB-4 test, and type IV collagen 7s were compared with histological findings. Results Greatest areas under the receiver operating characteristics curve (Az) with the single model were 0.83 (95 % confidence interval 0.71–0.91) for marked fibrosis (≥F2) by FIB-4 test; 0.85 (0.73–0.92) for advanced fibrosis (≥F3) by LSM, and 0.92 (0.83–0.96) by type IV collagen 7s for cirrhosis (F4). When combined, Az for marked fibrosis was ≥0.82; the best Az value was 0.87 (0.74–0.94) for the combination of contrast parameter with FIB-4. Similarly, the Az for advanced fibrosis was ≥0.82, and the best Az value was 0.89 (0.78–0.94) for the combination of contrast parameter with LSM. The Az for cirrhosis was ≥0.95, and the best Az was 0.99 (0.97–1.00) for the combination of contrast parameter with LSM. Conclusions The contrast parameter is a promising predictor for grading hepatic fibrosis when combined with LSM or FIB-4.
- 27 April 2012
- Published by Springer Nature in Hepatology International
- Vol. 7 (2) , 749-757
Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models
Purpose To elucidate the efficiency of contrast-enhanced ultrasonography alone and in combination with other noninvasive models for grading hepatic fibrosis. Methods This prospective study included 74 patients with four grades (F1–F4) of chronic liver disease (17, 20, 18, and 19 patients, respectively). Diagnostic performances of the contrast parameter (time to the maximum intensity ratio between the right portal vein and liver parenchyma from the onset of contrast enhancement in the right portal vein) assessed by ultrasonography, liver stiffness measurement (LSM), FIB-4 test, and type IV collagen 7s were compared with histological findings. Results Greatest areas under the receiver operating characteristics curve (Az) with the single model were 0.83 (95 % confidence interval 0.71–0.91) for marked fibrosis (≥F2) by FIB-4 test; 0.85 (0.73–0.92) for advanced fibrosis (≥F3) by LSM, and 0.92 (0.83–0.96) by type IV collagen 7s for cirrhosis (F4). When combined, Az for marked fibrosis was ≥0.82; the best Az value was 0.87 (0.74–0.94) for the combination of contrast parameter with FIB-4. Similarly, the Az for advanced fibrosis was ≥0.82, and the best Az value was 0.89 (0.78–0.94) for the combination of contrast parameter with LSM. The Az for cirrhosis was ≥0.95, and the best Az was 0.99 (0.97–1.00) for the combination of contrast parameter with LSM. Conclusions The contrast parameter is a promising predictor for grading hepatic fibrosis when combined with LSM or FIB-4.
- Open Access
- 1 January 2012
- Published by The Atomic Energy Society of Japan in Progress in Nuclear Science and Technology
- Vol. 3, 109-111
Dependence of Crystal Structures and Scintillation Properties on Cerium Concentration in Gd2Si2O7:Ce Powder Synthesized by Solid State Reaction
- 1 January 2012
- Published by The Atomic Energy Society of Japan in Progress in Nuclear Science and Technology
- Vol. 3, 109-111
Open AccessDependence of Crystal Structures and Scintillation Properties on Cerium Concentration in Gd2Si2O7:Ce Powder Synthesized by Solid State Reaction
- Open Access
- 30 December 2011
- Published by Springer Nature in European Radiology
- Vol. 22 (5) , 1083-1090
Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis
Objectives To examine the feasibility of perflubutane-based ultrasound for grading hepatic fibrosis. Methods This prospective study included 202 subjects; main study (controls:33, F0–1:35, F2:26, F3:23, cirrhosis:29) and subsequent study (controls:16, F0–1:7, F2:20, F3:7, cirrhosis:6). Diagnostic abilities for assessing fibrosis grade were compared between contrast findings and FIB4 (age × AST/[platelet count × ALT0.5]). Results High-power emission produced an intrahepatic band-like structure, and the three-layer appearance was less frequent and monolayer appearance was more frequent in cirrhosis than controls/chronic hepatitis (P < 0.0001). Intensity difference at 15-min phase showed most significant correlation with fibrosis grade (ρ = 0.79, P < 0.0001), and the best areas under the receiver operating characteristic curves are 0.88 for marked fibrosis, 0.95 for advanced fibrosis and 0.97 for cirrhosis, which were significantly higher than those of FIB4, 0.85 for marked fibrosis, 0.89 for advanced fibrosis and 0.90 for cirrhosis. Sensitivity, specificity and efficiency of the intensity difference were 88%, 72% and 81% for marked fibrosis, 85%, 91% and 89% for advanced fibrosis and 97%, 90% and 91% for cirrhosis, respectively. The subsequent study validated the main study results; significant correlation between the intensity difference and the fibrosis grade (ρ = 0.73–0.77, P < 0.0001). Conclusions Perflubutane-based ultrasound accurately predicts the grade of hepatic fibrosis. Key Points • The behaviour of intrahepatic microbubbles depends on the severity of hepatic fibrosis. • Layer enhancement pattern simply represents the degree of chronic liver disease. • Parenchymal intensity change due to high-power emission predicts the hepatic fibrosis grade.
- 30 December 2011
- Published by Springer Nature in European Radiology
- Vol. 22 (5) , 1083-1090
Open AccessDemonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis
Objectives To examine the feasibility of perflubutane-based ultrasound for grading hepatic fibrosis. Methods This prospective study included 202 subjects; main study (controls:33, F0–1:35, F2:26, F3:23, cirrhosis:29) and subsequent study (controls:16, F0–1:7, F2:20, F3:7, cirrhosis:6). Diagnostic abilities for assessing fibrosis grade were compared between contrast findings and FIB4 (age × AST/[platelet count × ALT0.5]). Results High-power emission produced an intrahepatic band-like structure, and the three-layer appearance was less frequent and monolayer appearance was more frequent in cirrhosis than controls/chronic hepatitis (P < 0.0001). Intensity difference at 15-min phase showed most significant correlation with fibrosis grade (ρ = 0.79, P < 0.0001), and the best areas under the receiver operating characteristic curves are 0.88 for marked fibrosis, 0.95 for advanced fibrosis and 0.97 for cirrhosis, which were significantly higher than those of FIB4, 0.85 for marked fibrosis, 0.89 for advanced fibrosis and 0.90 for cirrhosis. Sensitivity, specificity and efficiency of the intensity difference were 88%, 72% and 81% for marked fibrosis, 85%, 91% and 89% for advanced fibrosis and 97%, 90% and 91% for cirrhosis, respectively. The subsequent study validated the main study results; significant correlation between the intensity difference and the fibrosis grade (ρ = 0.73–0.77, P < 0.0001). Conclusions Perflubutane-based ultrasound accurately predicts the grade of hepatic fibrosis. Key Points • The behaviour of intrahepatic microbubbles depends on the severity of hepatic fibrosis. • Layer enhancement pattern simply represents the degree of chronic liver disease. • Parenchymal intensity change due to high-power emission predicts the hepatic fibrosis grade.